Fluvoxamine Mediates Specific, Early, and Delayed SARS-CoV-2 Protection through Antioxidant and Cytoprotective Pathways via Sigma-1 Receptor Agonism

Detalles Bibliográficos
Autores principales: Papadopoulos, Konstantinos, Papadopoulou, Alexandra, Aw, Tar Choon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tabriz University of Medical Sciences 2023
Materias:
Letter to Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460798/
https://www.ncbi.nlm.nih.gov/pubmed/37646061
http://dx.doi.org/10.34172/apb.2023.045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460798/
https://www.ncbi.nlm.nih.gov/pubmed/37646061
http://dx.doi.org/10.34172/apb.2023.045

Ejemplares similares